4//SEC Filing
Chondros Dimitrios 4
Accession 0001179110-19-001934
CIK 0001159036other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:28 PM ET
Size
7.6 KB
Accession
0001179110-19-001934
Insider Transaction Report
Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Award
Option to Purchase Common Stock
2019-02-12+71,602→ 71,602 totalExercise: $16.65From: 2020-02-12Exp: 2029-02-12→ Common Stock (71,602 underlying) - Award
Restricted Stock Units
2019-02-12+37,538→ 37,538 totalExercise: $0.00From: 2020-02-12→ Common Stock (37,538 underlying)
Footnotes (2)
- [F1]This option vests one-fourth on such date and then 1/48th monthly thereafter.
- [F2]This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.
Documents
Issuer
HALOZYME THERAPEUTICS INC
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001739693
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:28 PM ET
- Size
- 7.6 KB